Edition:
India

Deutsche Euroshop AG (DEQGn.DE)

DEQGn.DE on Xetra

12.52EUR
10 Aug 2020
Change (% chg)

-- (--)
Prev Close
€12.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
286,107
52-wk High
€27.54
52-wk Low
€9.46

Latest Key Developments (Source: Significant Developments)

Deutsche EuroShop AG scraps 2020 outlook due to coronavirus crisis
Friday, 3 Apr 2020 

April 2 (Reuters) - Deutsche EuroShop AG ::DGAP-ADHOC: SUSPENSION OF FORECAST FOR 2020 - CURRENT INFORMATION ON DEUTSCHE EUROSHOP'S BUSINESS PERFORMANCE IN VIEW OF THE ONGOING SPREAD OF THE CORONAVIRUS AND THE ENTRY INTO FORCE OF LAWS TO MITIGATE THE EFFECTS OF THE PANDEMIC.SAYS SINCE MID-MARCH MAJORITY OF SHOPS IN SHOPPING CENTERS OF DEUTSCHE EUROSHOP AG (DES) HAVE BEEN OFFICIALLY ORDERED TO CLOSE TO PROTECT POPULATION AND CONTAIN CORONAVIRUS PANDEMIC.SAYS FURTHER SPREAD OF PANDEMIC AND EXTENSION OF OFFICIAL REQUIREMENTS HAVE FURTHER AGGRAVATED ECONOMIC SITUATION IN GENERAL AND FOR BRICKS AND MORTAR RETAILING IN PARTICULAR.SAYS A EUR 70 MILLION AGREEMENT WAS SIGNED AS PLANNED ON 26 MARCH 2020 TO REFINANCE LOANS MATURING IN 2020.  Full Article

Deutsche EuroShop to increase dividend to 1.50 eur per share
Wednesday, 27 Feb 2019 

Feb 27 (Reuters) - Deutsche Euroshop AG says::POSITIVE OPERATING PERFORMANCE - PRELIMINARY RESULTS FOR 2018 AHEAD OF FORECAST.REVENUE: EUR225.0 MILLION (+3.0%).EBIT: EUR199.1 MILLION (+3.5%).FFO: EUR150.4 MILLION (+1.5%).EBT EXCLUDING VALUATION: EUR160.9 MILLION (+5.0%).NAV STABLE: EUR43.17 PER SHARE.DIVIDEND PROPOSAL (PLANNED): EUR1.50 PER SHARE (+3.4%).  Full Article

BRIEF-Daiichi Sankyo Initiates Clinical Trial With In Collaboration With Sarah Cannon Research Institute

* DAIICHI SANKYO INITIATES CLINICAL TRIAL WITH 5TH DXD ADC, DS-6157, IN COLLABORATION WITH SARAH CANNON RESEARCH INSTITUTE Source text for Eikon: Further company coverage: